This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
The clinical data that support the findings of this study are publicly available at BioLINCC: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (0702) (nih.gov). DNA methylation data will be shared upon reasonable request with the corresponding author.
D’Souza A, Brazauskas R, Stadtmauer EA, Pasquini MC, Hari P, Bashey A, et al. Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma. Am J Hematol. 2022. https://doi.org/10.1002/ajh.26596.
Bartlett AH, Liang JW, Sandoval-Sierra JV, Fowke JH, Simonsick EM, Johnson KC, et al. Longitudinal study of leukocyte DNA methylation and biomarkers for cancer risk in older adults. Biomark Res. 2019;7:10. https://doi.org/10.1186/s40364-019-0161-3.
Joyce BT, Gao T, Zheng Y, Liu L, Zhang W, Dai Q, et al. Prospective changes in global DNA methylation and cancer incidence and mortality. Br J Cancer. 2016;115:465–72. https://doi.org/10.1038/bjc.2016.205.
Rodriguez RM, Suarez-Alvarez B, Salvanes R, Muro M, Martinez-Camblor P, Colado E, et al. DNA methylation dynamics in blood after hematopoietic cell transplant. PLoS One. 2013;8:e56931. https://doi.org/10.1371/journal.pone.0056931.
Wong Doo N, Makalic E, Joo JE, Vajdic CM, Schmidt DF, Wong EM, et al. Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms. Epigenomics. 2016;8:55–66. https://doi.org/10.2217/epi.15.97.
Muylaert C, Van Hemelrijck LA, Maes A, De Veirman K, Menu E, Vanderkerken K, et al. Aberrant DNA methylation in multiple myeloma: a major obstacle or an opportunity? Front Oncol. 2022;12:979569. https://doi.org/10.3389/fonc.2022.979569.
Stadtmauer EA, Pasquini MC, Blackwell B, Hari P, Bashey A, Devine S, et al. Autologous transplantation, consolidation, and maintenance therapy in multiple myeloma: results of the BMT CTN 0702 Trial. J Clin Oncol. 2019;37:589–97. https://doi.org/10.1200/JCO.18.00685.
Pan H, Renaud L, Chaligne R, Bloehdorn J, Tausch E, Mertens D, et al. Discovery of candidate DNA methylation cancer driver genes. Cancer Discov. 2021;11:2266–81. https://doi.org/10.1158/2159-8290.CD-20-1334.
Chakraborty R, Hamilton BK, Hashmi SK, Kumar SK, Majhail NS. Health-related quality of life after autologous stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2018;24:1546–53. https://doi.org/10.1016/j.bbmt.2018.03.027.
Cerutti J, Lussier AA, Zhu Y, Liu J, Dunn EC. Associations between indicators of socioeconomic position and DNA methylation: a scoping review. Clin Epigenetics. 2021;13:221. https://doi.org/10.1186/s13148-021-01189-0.
This ancillary study was funded by a Froedtert & MCW Cancer Center grant (project 3379013). AD is supported by K23 HL141445. The BMT CTN 0702 was supported by Grant No. U10HL069294 to the Blood and Marrow Transplant Clinical Trials Network from the National Heart, Lung, and Blood Institute and the National Cancer Institute; by Celgene Corporation and Millennium (Takeda) Pharmaceuticals; and by The Alliance for Clinical Trials in Oncology, the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group, and SWOG. The content of this article is solely the responsibility of the authors and does not represent the official views of the funding parties.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
D’Souza, A., Brazauskas, R., Teng, B.Q. et al. DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma. Bone Marrow Transplant 58, 334–336 (2023). https://doi.org/10.1038/s41409-022-01887-0